来源：芝麻AI 一、市场: ●2月24日收盘：美股大幅收跌 特朗普关税大棒打压市场 北京时间2月24日凌晨，美股周一大幅收跌，道指、纳指、标普500指数均下跌。原因一是人工智能颠覆 担忧发酵，IBM重挫；二是特朗普在最高法院否决其"对等"关税后要提高全球关税，他将税率从10%提 至15%，还称未来有更多征税措施。这增大美股压力，欧洲议会暂停美欧贸易协定批准工作。新关税引 发市场对通胀和增长前景的担忧，金价上涨，比特币暴跌。此外，围绕特朗普关税政策的波动或持续， 后续走势受关注。 [1] ●2月24日美股成交额前20：IBM股价重挫13%，核心业务面临AI威胁 周一美股成交额前20中多只股票有重要动态。英伟达收高，宣布与多家公司合作引入AI到OT网络安全 领域，获券商上调评级；特斯拉收跌，推出Cybertruck新车型，价格或依需求调整。微软收跌，调查美 用户访问服务问题；闪迪收高，推出开源工具。Palantir、Meta、CrowdStrike等收跌。礼来收高，为减 肥药Zepbound推出新剂型。IBM重挫，因Claude Code工具可改造其核心COBOL业务。诺和诺德收跌， 新一代减肥药试验效果不如礼来 ...

Group 1 - Goldman Sachs strategists predict a strong rebound in the U.S. IPO market, driven by a stable economy, increased board confidence, and expected continued accommodative monetary policy [1][8] - The projected IPO fundraising amount for 2026 is approximately $160 billion, significantly higher than last year's $48 billion, excluding SPACs and other fundraising types [1][8] - The number of IPOs is expected to rise to 120 in 2026, nearly doubling from the previous year, indicating a return to normal levels rather than speculative market exuberance [2][8] Group 2 - Recent IPO activity has been mixed, with notable companies experiencing both significant gains and losses upon their market debut [2] - Key risks for the IPO market include potential market volatility, which could hinder the expansion of actual IPO sizes, as seen in recent global market fluctuations [2] - Major private companies like SpaceX and OpenAI are preparing for IPOs, with SpaceX potentially raising up to $50 billion and OpenAI's valuation expected to approach $1 trillion [5][6] Group 3 - The resurgence of IPO activity is crucial for the bullish trend in the U.S. stock market, as it reflects increased risk appetite and favorable financing conditions [8] - Historical data suggests that significant increases in IPO activity, especially from major companies, are often associated with strong returns in the S&P 500 index [4][8] - Other companies to watch for potential IPOs include Canva, Strava, and Databricks, indicating a broader wave of IPO activity anticipated in the coming years [7]

Group 1 - The core viewpoint is that the Dow Jones Industrial Average (DJIA) has seen a shift in momentum from technology stocks to a broader range of sectors, benefiting traditional and defensive sectors significantly [2] - Notable performers in the DJIA include Goldman Sachs (GS.US), Caterpillar (CAT.US), Amgen (AMGN.US), and Sherwin-Williams (SHW.US), which have contributed to the index's upward movement [2] - The DJIA's price-weighted calculation means that higher-priced components have a more substantial impact on the index compared to market-cap weighted indices, with Boeing's recent stock strength also providing support [2] Group 2 - Gina Bolvin, president of Bolvin Wealth Management Group, states that the DJIA's breakthrough of 50,000 points is more of a confirmation than a celebration, indicating that the market has adapted to higher interest rates and slower growth while still rising [3] - The resilience of healthcare stocks is becoming evident, with Johnson & Johnson (JNJ.US) and Merck (MRK.US) being the second and fifth best-performing components in the DJIA over the past 12 months [3] - Investors are increasing allocations to high-dividend and defensive consumer staples stocks, with Coca-Cola (KO.US) and Walmart (WMT.US) ranking among the top gainers in the DJIA over the past year [3] - Despite the market's broadening focus, technology and AI sectors remain strong, with Nvidia (NVDA.US) seeing a 44% increase in stock price over the past year, making it the third-largest gainer in the DJIA [3]

Core Viewpoint - Tencent has shifted its investment strategy from a broad approach focused on "traffic + capital" to a more concentrated focus on high-tech sectors such as AI, healthcare, and smart hardware, reflecting changes in the regulatory environment and market dynamics [4][5]. Investment Trends - Over the past five years, Tencent's investment pace has significantly decreased, with the number of external investments dropping from 296 in 2021 to an estimated 25 in 2024, before a slight recovery to 37 in 2025 [4][6]. - The company has invested in over 800 enterprises, with more than 70 successfully listed and over 160 becoming unicorns valued at over $1 billion [4]. AI Investment Focus - Tencent has designated 2025 as the "AI Year," with projected capital expenditures in AI reaching hundreds of billions [6]. - The investment strategy includes a systematic approach to AI, focusing on foundational computing, basic models, and application-level AI tools [6][8]. - Significant investments include a $15 billion round for optical hybrid computing provider Xizhi Technology and a $5 billion investment in Moonlight Dark, a model layer investment [6][8][9]. Healthcare Investments - Tencent's healthcare investments have shifted towards innovative drugs, biotechnology, and high-end medical devices, moving away from earlier focuses on online consultations and pharmaceutical e-commerce [11][12]. - Notable investments include a stake in Libang Pharmaceutical, focusing on chronic kidney disease treatments, and participation in various funding rounds for companies targeting major diseases like cancer and metabolic disorders [12][13]. Gaming Sector Strategy - Tencent continues to invest in its core gaming business, acquiring companies like Mengyou Technology to enhance its casual gaming offerings and expanding its global presence through acquisitions like Ubisoft's Vantage Studios [16][17]. - The company is also exploring next-generation interactive forms, such as AI-driven social gaming platforms [18][19]. Hard Technology and Manufacturing - Tencent is expanding its investments into advanced manufacturing, focusing on robotics and autonomous delivery systems, with significant funding in companies like Zhiyuan Robotics and Neolix [20][21]. - The company is also investing in green technology, including carbon capture and electric vehicle charging solutions [21]. Consumer and Retail Investments - Tencent is actively investing in consumer brands and retail sectors, with notable investments in tea brands and outdoor products, as well as exploring opportunities in overseas markets [22][23]. - The company is also focusing on consumer technology, investing in brands like xTool, which specializes in laser creative tools [23].

Economic Performance - Chengdu's GDP for 2025 is projected to be 24,763.6 billion yuan, reflecting a 5.8% increase from the previous year at constant prices [1] - Fixed asset investment in Chengdu grew by 2.2% year-on-year, outperforming national and provincial averages by 6 and 4.6 percentage points respectively [6] - The total retail sales of social consumer goods reached 11,434.1 billion yuan, marking a 5.5% increase from the previous year [1] - Foreign trade imports and exports hit a record high of 8,502.3 billion yuan [1][21] Investment and Project Development - Chengdu initiated a "100-day special action" to promote project investment, resulting in significant improvements in project initiation and quality [6][7] - In 2025, 995 key projects completed investments of 3,809.8 billion yuan, exceeding the annual plan by 12.6 percentage points [7] - The opening rate of projects reached 97.1%, an increase of 32.9 percentage points compared to before the special action [7] Industrial Development - Chengdu is implementing the "Stand Park Full Park" initiative, optimizing a park system of "3+22+N" to support industrial growth [8] - The city is focusing on 17 key industrial chains to strengthen, extend, and supplement these chains through a "chain leader + special class" approach [8] - Chengdu has established 14 billion-level parks and 26 500-million-level parks, which significantly contribute to the city's economic development [15] Innovation and Technology - Chengdu has launched several innovative projects, including the world's first 150-inch Fresnel optical screen and a new radioactive drug for pancreatic cancer [5][9][12] - The establishment of the Tianfu Jiangxi Laboratory for humanoid robots signifies Chengdu's commitment to advancing in cutting-edge technology [10] - The city has introduced policies to enhance low-altitude flight capabilities and foster a low-altitude economy [12] Economic Strategy and Governance - Chengdu's economic strategy emphasizes innovation-driven development, open leadership, and integration of science and industry [16] - The city has developed a "1+7+365" service system to support enterprises, achieving a 99.3% completion rate for business requests [16][18] - Chengdu is actively participating in national strategies such as the Belt and Road Initiative and the Chengdu-Chongqing Economic Circle [20][21]

Group 1 - The core viewpoint of the articles indicates that the A-share and Hong Kong stock markets are experiencing a significant turning point, with a shift from value/defensive stocks to growth and cyclical sectors, driven by macroeconomic recovery, policy support, improved liquidity, and easing geopolitical tensions [1][10] - Morgan Stanley maintains its core index target for MSCI China at 100 points (17% upside) and an optimistic target of 120 points (41% upside), while the CSI 300 index targets are set at 5200 points (10% upside) and 6000 points (27% upside) [2] - The shift in market style has been validated, with growth sectors such as communication services, information technology, and healthcare showing strong performance since mid-December, while A-share market turnover increased by 0.9 percentage points from November to December [2][3] Group 2 - Morgan Stanley upgraded its investment rating for consumer discretionary and healthcare sectors from "neutral" to "overweight," alongside previously upgraded sectors like communication services and information technology, forming a clear growth and cyclical allocation strategy [3][4] - The logic behind the overweight sectors includes recovery in consumer demand driven by policy implementation and rising income expectations, as well as the acceleration of innovative drug development in healthcare [4] - Key recommended stocks include leading companies across various sectors, such as NetEase, Baidu, and Pinduoduo in internet technology, Kweichow Moutai and Haitian Flavoring in consumer, and CATL and Zijin Mining in cyclical growth [4] Group 3 - The "4+1" thematic trading framework is expected to gain momentum in the first quarter of 2026, with multiple catalysts [5][6] - Key areas of focus include stable U.S.-China relations benefiting leading exporters, accelerated AI infrastructure and energy storage demand, and recovery in industries affected by overcapacity [6] - The real estate sector is expected to stabilize due to comprehensive support policies, with measures like lower mortgage rates and funding for project completion driving supply-demand balance [6] Group 4 - Morgan Stanley identifies two main sources of capital inflow supporting the Chinese stock market: the maturity of approximately 57% of onshore deposits in 2026 and the expanding trade surplus, which is projected to reach $1.1 trillion in 2025 [7][8] - The macroeconomic outlook is positive, with GDP growth rates expected to be 5.0% in 2025 and 4.5% in 2026, alongside the best earnings growth cycle since 2020 for MXCN and CSI 300 [8] - The easing of geopolitical tensions and the commencement of a U.S. interest rate cut cycle are anticipated to attract foreign capital inflows, with $27 billion in foreign net inflows recorded in December 2025 [8]

Market Overview - The Hang Seng Index closed at 26,999.8 points, up 0.6%, while the Hang Seng China Enterprises Index rose 0.3% to 9,315.6 points[1] - Trading volume increased to HKD 340.4 billion, an 8.0% rise from the previous day's HKD 315.2 billion, indicating a potential portfolio reallocation by investors[1] - Non-essential consumer, healthcare, and materials sectors saw increases of 2.2%, 1.3%, and 1.0% respectively, while utilities, industrials, and financials declined by 0.4%, 0.2%, and 0.2%[1] Stock Performance - Alibaba Health (241 HK) and Haidilao (6862 HK) led the gainers, rising 19.0% and 9.2% respectively[1] - Ctrip Group (9961 HK) and Xinyi Glass (868 HK) were the biggest losers, falling 6.5% and 3.9% respectively[1] Regulatory Developments - Ctrip Group is under investigation for alleged monopolistic practices, which may benefit the industry by ensuring better protection for businesses and consumers in the long run[1] - The China Securities Regulatory Commission approved an increase in the minimum financing margin ratio from 80% to 100%, aimed at reducing leverage and promoting market stability[1] Macro Dynamics - China's exports in December increased by 6.6% year-on-year, surpassing November's 5.9% and market expectations of 3.0%[3] - U.S. retail sales rose by 0.6% in November, better than October's decline of 0.1% and exceeding the forecast of 0.4%[3] Industry Insights - Macau's gaming revenue is projected to grow by 15%-20% year-on-year in January, with a strong start in the first week showing an 18% increase[4] - China Biologic Products (1177 HK) announced a maximum acquisition price of RMB 1.2 billion for Hejiya, focusing on innovative drug development in metabolic diseases[5] - The healthcare index rose by 1.3%, with China Biologic Products increasing by 2.9% following the acquisition announcement[5]

Group 1 - AI healthcare concept stocks have strengthened, with notable increases in share prices for companies such as Alibaba Health (+18.81%), MicroPort Scientific (+7.7%), Yidu Tech (+6.06%), Ping An Good Doctor (+5.9%), and JD Health (+4.08%) [1] - NVIDIA and Eli Lilly announced a joint investment of $1 billion to establish an AI drug development lab in San Francisco, aimed at accelerating drug development processes [1] - NVIDIA has previously invested in biotechnology company Recursion and established partnerships with leading firms in the healthcare sector, including Novo Nordisk and Mayo Clinic [1] Group 2 - Citic Securities believes that AI in healthcare will accelerate the restructuring of the trillion-dollar pharmaceutical market, with a fundamental change in the logic of AI healthcare expected by 2026 [2] - The core of this change is that the payers for AI healthcare have become clearer and more powerful this year, indicating a stronger certainty for commercialization in 2026 [2]

Group 1 - Baidu Group-SW (09888) proposes to spin off Kunlun Chip for independent listing on the Hong Kong Stock Exchange main board [1] - Dali Group Holdings (01921) subsidiary Dali International Industrial Company has obtained a temporary industrial license issued by MIMR [1] - Guofu Hydrogen Energy (02582) has completed the delivery of a total of 424 sets of vehicle-mounted high-pressure hydrogen supply systems to its customers [1] Group 2 - CSPC Pharmaceutical Group (01093) has received clinical trial approval in China for its inhalation powder of Nintedanib [1] - Fantasia Holdings (01777) has entered into a restructuring agreement with Splendid Fortune to sell 409 million shares of Color Life for USD 4.5284 million [1] - China Hongqiao (01378) has made Hongtuo Industrial a wholly-owned subsidiary of Hongchuang Holdings [1] Group 3 - Brainstorm Cell Therapeutics-B (06681) subsidiary has officially signed a cooperation agreement with Beijing Jianguo Medical for a cognitive digital therapy project [1] - Longpan Technology (02465) plans to invest in a lithium iron phosphate production base with an annual capacity of 240,000 tons, with a total investment not exceeding 2 billion yuan [1] - Zhongzheng International (00943) intends to acquire a digital solution company in the beauty industry for HKD 62.5 million, with resumption of trading on January 5 [1] - Kelun-Biotech (06990) has received approval from the National Medical Products Administration for the clinical trial application of its ITGB6 ADC SKB105 new drug [1]

Market Movements - US stock index futures are all up, with Dow futures rising by 0.23%, S&P 500 futures up by 0.34%, and Nasdaq futures increasing by 0.44% [1] - European indices show mixed results, with Germany's DAX down by 0.01%, UK's FTSE 100 up by 1.63%, France's CAC40 down by 0.15%, and the Euro Stoxx 50 up by 0.12% [1] Oil Prices - WTI crude oil has increased by 1.74%, reaching $56.09 per barrel, while Brent crude oil is up by 1.63%, priced at $59.88 per barrel [2] Economic and Market News - President Trump is expected to interview Federal Reserve Governor Christopher Waller for the Fed Chair position, with the process moving quickly [3] - Traders are showing less concern regarding the upcoming CPI report, with expectations of only a 0.7% volatility in the S&P 500 index, significantly lower than the 1% average seen in previous months [3] Oil Market Insights - Oil prices have rebounded from four-year lows due to geopolitical tensions in Venezuela, with the country’s oil production recovering but still below historical levels [4] - Goldman Sachs indicates that the Federal Reserve may be more willing to cut rates next year, influenced by cautious labor market data [4] Technology and AI Investments - Concerns over AI financing are deemed exaggerated, with Goldman Sachs stating that $700 billion to $1 trillion in capital expenditures will be supported by operational cash flow [5] - Amazon is reportedly in talks to invest $10 billion in OpenAI, which would enhance its competitive position against Nvidia in the AI chip market [5] - Nvidia and SK Hynix are collaborating on an AI SSD that aims to achieve up to 1 million IOPS, significantly improving performance [7] Company Developments - Warner Bros. is set to reject a hostile takeover bid from Paramount due to concerns over financing and terms, favoring its existing agreement with Netflix [6][7] - Waymo, Alphabet's autonomous driving unit, is seeking to raise over $15 billion at a valuation nearing $100 billion [8] - GlaxoSmithKline's new asthma drug has received FDA approval, which could position it as a significant product in the market [9]